Effect of double platinum agents, combination of miriplatin-transarterial oily chemoembolization and cisplatin-hepatic arterial infusion chemotherapy, in patients with hepatocellular carcinoma: Report of two cases

Table 1 Results of laboratory investigation of case 1 on the day of the admission

Hematology		Biochemistry
WBC	5100/μL	TP	7.3 g/dL	Na	142 mEq/L
RBC	399 × 104/μL	Alb	4.5 g/dL	K	2.9 mEq/L
Hb	14.1 g/dL	BUN	7 mg/dL	Cl	101 mEq/L
Ht	41.80%	Cre	0.44 mg/dL	CRP	0.50 mg/dL
PLT	7.4 × 104/μL	T-Bil	0.8 mg/dL	AFP	7 ng/mL
Coagulation		D-Bil	0.1 mg/dL	AFP-L3	< 0.5%
PT	85%	AST	28 IU/L	DCP	24 mAU/mL
		ALT	20 IU/L	CEA	5.8 ng/mL
		ChE	211 IU/L	CA 19-9	68 U/mL
		LDH	181 IU/L
		γ-GTP	256 IU/L

WBC: White blood cell; RBC: Red blood cell; PLT: Platelet; PT: Prothrombin time; TP: Total protein; BUN: Blood urea nitrogen; AST: Aspartate aminotransferase; ALT: Alanine transaminase; LDH: Lactate dehydrogenase; γ-GTP: γ-glutamyltransferase; CRP: C-reactive protein; AFP: Alpha-fetoprotein; DCP: des-γ-carboxy prothrombin; CEA: Carcinoembryonic antigen.

Table 2 Results of laboratory investigation of case 2 before miriplatin- transarterial oily chemoembolization/DDP-H-hepatic arterial infusion chemotherapy combination therapy

Hematology		Biochemistry
WBC	3980 /μL	TP	7.0 g/dL	Na	138 mEq/L
RBC	344 × 104/μL	Alb	3.1 g/dL	K	3.5 mEq/L
Hb	10.2 g/dL	BUN	11 mg/dL	Cl	106 mEq/L
Ht	30.00%	Cre	0.45 mg/dL	CRP	0.16 mg/dL
PLT	8.6 × 104/μL	T-Bil	0.7 mg/dL	AFP	4 ng/mL
Coagulation		D-Bil	0.1 mg/dL	AFP-L3	< 0.5%
PT	52%	AST	63 IU/L	DCP	< 15 mAU/mL
		ALT	49 IU/L	CEA	2.2 ng/mL
		ChE	124 IU/L	CA 19-9	40 U/mL
		LDH	143 IU/L
		γ-GTP	83 IU/L

WBC: White blood cell; RBC: Red blood cell; PLT: Platelet; PT: Prothrombin time; TP: Total protein; BUN: Blood urea nitrogen; AST: Aspartate aminotransferase; ALT: Alanine transaminase; LDH: Lactate dehydrogenase; γ-GTP: γ- glutamyltransferase; CRP: C-reactive protein; AFP: Alpha-fetoprotein; DCP: des-γ-carboxy prothrombin; CEA: Carcinoembryonic antigen.